Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian neurosurgical society

Canadian Journal of Neurological Sciences

Volumn 24, Issue 2, 1997, Pages 161-170

  Findlay, J M ^a   Fewer, H D ^b   Gittens, W O ^b   Griebel, R W ^b   Holness, R O ^b   Hugenholtz, H ^b   Redekop, G J ^b   Steinke, D E ^b   Wallace, M C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICONVULSIVE AGENT; ANTIFIBRINOLYTIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; DESMOPRESSIN; DOBUTAMINE; DOPAMINE; HYDRALAZINE; INOTROPIC AGENT; LABETALOL; MANNITOL; NIMODIPINE; NORADRENALIN; PHENYLEPHRINE; PHENYTOIN;

BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES INSIPIDUS; FLUID THERAPY; HEADACHE; HUMAN; HYPERTENSION; INAPPROPRIATE VASOPRESSIN SECRETION; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBARACHNOID HEMORRHAGE; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL TECHNIQUE;

EID: 0030961632     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100021521     Document Type: Review

References (115)

1. Phillips LHD, Whisnant JP, O'Fallon WM, Sundt TM Jr. The unchanging pattern of subarachnoid hemorrhage in a community. Neurology 1980; 30(10): 1034-1040.
2. Bonita R, Thomson S. Subarachnoid hemorrhage: epidemiology, diagnosis, management, and outcome. Stroke 1985; 16(4): 591-594.
3. Sundt TM Jr, Whisnant JP. Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease. N Engl J Med 1978; 299(3): 116-122.
4. Canadian Task Force on the Periodic Health Examination: The periodic health examination: 2. 1987 update. Can Med Assoc J 1988; 138: 618-626.
5. Mayberg MR, Batjer HH, Dace R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 1994; 25: 2315-2328.
6. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circ. 1994; 90(5): 2592-2605.
7. Botterell EH, Lougheed WM, Scott JW, Vandewater SL. Hypothermia and interruption of carotid and vertebral circulation in the surgical management of intracranial aneurysms. J Neurosurg 1956; 13: 1-42.
8. Lougheed WM, Marshall, BM. Management of aneurysms of the anterior circulation by intracranial procedures. In: Youmans JR, ed. Neurological Surgery, Philadelphia: W.B. Saunders, 1973; 2: 731-767.
9. Hunt WE, Hess, RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28: 14-20.
10. Drake CG. Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale (Neurosurgical forum). J Neurosurg: 1988; 68: 985-986.
11. Bassi P, Bandera R, Loiero M, Tognoni G, Mangoni A. Warning signs in subarachnoid hemorrhage: a cooperative study. Acta Neurol Scand 1991; 84(4): 277-281.
12. Leblanc R, Winfield JA. The warning leak in subarachnoid hemorrhage and the importance of its early diagnosis. Can Med Assoc J 1984; 131(10): 1235-1236.
13. Duffy GP. The "warning leak" in spontaneous subarachnoid haemorrhage. Med J Aust 1983; 1(11): 514-516.
14. Vermeulen M, van Gijn J. The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53(5): 365-372.
15. Adams HP Jr, Kassell NF, Torner JC, Sahs AL. CT and clinical correlations in recent aneurysmal subarachnoid hemorrhage: a preliminary report of the Cooperative Aneurysm Study. Neurology 1983; 33(8): 981-988.
16. van Gijn J, van Dongen KJ. The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology 1982; 23(3): 153-156.
17. Kassell NF, Kongable GL, Torner JC, Adams HP, Jr., Mazuz H. Delay in referral of patients with ruptured aneurysms to neurosurgical attention. Stroke 1985; 16(4): 587-590.
18. Weir B, Myles T, Kahn M, et al. Management of acute subdural hematomas from aneurysmal rupture. Can J Neurol Sci 1984; 11: 371-376.
19. Duffy GP. Lumbar puncture in spontaneous subarachnoid haemorrhage. Br Med J - Clinical Research Ed 1982; 285(6349): 1163-1164.
20. Soderstrom CE. Diagnostic significance of CSF spectrophotometry and computer tomography in cerebrovascular disease. A comparative study in 231 cases. Stroke 1977; 5: 606-612.
21. Alberico RA, Patel M, Casey S, et al. Evaluation of the Circle of Willis with three-dimensional CT angiography in patients with suspected intracranial aneurysms. Am J Neuroradiol 1995; 16: 1571-1578.
22. Dorsch NWC, Young N, Kingston RJ, Compton JS. Early experience with spiral CT in the diagnosis of intracranial aneurysms. Neurosurgery 1995; 36: 230-238.
23. Hsiang JNK, Liang EY, Lam JMK, Zhu X, Poon WS. The role of computed tomography angiography in the diagnosis of intracranial aneurysms and emergent aneurysm clipping. Neurosurgery 1996; 38(3): 481-487.
24. Kassell NF, Torner JC. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 1983; 13(5): 479-481.
25. Fujii Y, Shigekazu, T, Sasaki O, et al. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 1996; 84: 35-42.
26. Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ. Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 1990; 72: 559-566.
27. Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR. Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 1996; 85: 39-49.
28. Le Roux PD, Dailey AT, Newell DW, Grady MS, Winn, HR. Emergent aneurysm clipping without angiography in the moribund patient with intracerebral hemorrhage: the use of infusion computed tomography scans. Neurosurgery 1993; 33: 189-197.
29. Kassell NF, Drake CG. Timing of aneurysm surgery. Neurosurgery 1982; 10: 514-519.
30. O'Neill P, West CR, Chadwick DW, et al. Recurrent aneurysmal subarachnoid haemorrhage: incidence, timing and effects. A reappraisal in a surgical series. Br J Neurosurg 1988; 2(1): 43-48.
31. Mizukami M, Kawase T, Usami T, Tazawa T. Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 1982; 10(3): 301-307.
32. Taneda M. The significance of early operation in the management of ruptured intracranial aneurysms-an analysis of 251 cases hospitalized within 24 hours after subarachnoid haemorrhage. Acta Neurochir 1982; 63(1-4): 201-208.
33. Le Roux PD, Elliott JP, Newell DW, et al. The incidence of surgical complications is similar in good and poor grade patients undergoing repair of unruptured anterior circulation aneurysms: a retrospective review of 355 patients. Neurosurgery 1996; 38: 887-895.
34. Kassell NF, Torner JC, Jane JA, Haley ECJ, Adams HP. The international cooperative study on the timing of aneurysm surgery I: overall management results. J Neurosurg 1990; 73: 18-36.
35. Kassell NF, Torner JC, Jane JA, Haley ECJ, Adams HP. The international cooperative study on the timing of aneurysm surgery II: surgical results. J Neurosurg 1990; 73: 37-47.
36. Haley ECJ, Kassell NF, Torner JC, and the participants. The international cooperative study on the timing of aneurysm surgery. The North American experience. Stroke 1992; 23: 205-214.
37. Ohman J, Heiskanen O. Timing of operation for ruptured supratentorial aneurysms: a prospective study. J Neurosurg 1989; 70: 55-60.
38. Heiskanen O, Poranen A, Kuurne T, Valtonen S, Kaste M. Acute surgery for intracerebral haematomas caused by rupture of an intracranial arterial aneurysm. A prospective randomized study. Acta Neurochir 1988; 90(3-4): 81-83.
39. Batjer HH, Samson DS. Emergent aneurysm surgery without cerebral angiography for the comatose patient [see comments]. Neurosurgery 1991; 28(2): 283-287.
40. Guglielmi G, Vinuela F, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach, Part 1. Electrochemical basis, technique, and experimental results. J Neurosurg 1991; 75: 1-7.
41. Guglielmi G, Vinuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach, Part 2. Preliminary clinical experience. J Neurosurg 1991; 75: 8-14.
42. Guglielmi G, Vinuela F, Duckwiler G, et al. Endovascular treat-ment of posterior circulation aneurysms by electrothrombosis using electrically detached coils. J Neurosurg 1992; 77: 515-524.
43. Halbach V, Higashida R, Dowd C, et al. The efficacy of endosaccular aneurysm occlusion in alleviating neurological deficits produced by mass effect. J Neurosurg 1994; 80: 659-666.
44. Mawad M, Mawad J, Cartwright J, Gokaslan Z. Long-term histopathologic changes in canine aneurysms embolized with Guglielmi detachable coils. Am J Neuroradiol 1995; 16:7-13.
45. Nichols D. Endovascular treatment of the acutely ruptured intracranial aneurysm. J Neurosurg 1995; 79: 1-2.
46. Zubillaga A, Guglielmi G, Vinuela F, Duckwiler G. Endovascular occlusion of intracranial aneurysms with electrically detachable coils. Am J Neuroradiol 1994; 15: 815-820.
47. Casasco A, Aymard A, Gobin P, et al. Selective endovascular treatment of 71 intracranial aneurysms with platinum coils. J Neurosurg 1993; 79: 3-10.
48. Graves VB, Strother CM, Duff TA, Perl J. II. Early treatment of ruptured aneurysms with Guglielmi detachable coils: effect on subsequent bleeding. Neurosurgery 1995; 37: 640-648.
49. Gobin YP, Vinuela F, Gurian JH, et al. Treatment of large and giant fusiform intracranial aneurysms with Guglielmi detachable coils. J Neurosurg 1996; 84: 55-62.
50. McDougall CG, Halbach VV, Dowd CF, et al. Endovascular treatment of basilar tip aneurysms using electrolytically detachable coils. J Neurosurg 1996; 84: 393-399.
51. Zubillaga AF, Guglielmi G, Vinuela F, et al: Endovascular occlusion of intracranial aneurysms with electrically detachable coils: correlation of aneurysm neck size and treatment results. Am J Neuroradiol 1994; 15: 815-820.
52. Guglielmi G, Vinuela F, Duckwiler G, et al. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg 1992; 77: 515-524.
53. Pierot L, Boulin A, Castaings L, Rey A, Moret J. Selective occlusion of basilar artery aneurysms using controlled detachable coils: report of 35 cases. Neurosurgery 1996; 38(5): 948-954.
54. Civil T, Auque J, Marchai JC, et al. Aneurysm clipping after endovascular treatment with coils: a report of eight patients. Neurosurgery 1996; 38(5): 955-961.
55. Lawton MT, Hamilton MG, Morcos JJ, Spetzler RF. Revascularization and aneurysm surgery: current techniques, indications, and outcome. Neurosurgery 1996; 38: 83-94.
56. Winn HR, Richardson AE, Jane JA. Late morbidity and mortality of common carotid ligation for posterior communicating aneurysm: a comparison to conservative treatment. J Neurosurg 1977; 47: 727-736.
57. Jha AN, Butler P, Lye RH, Fawcitt RA. Carotid ligation: what happens in the long term? J Neurol Neurosurg Psychiatry 1986; 49(8): 893-898.
58. Fox AJ, Vinuela F, Pelz DM, et al. Use of detachable balloons for proximal artery occlusion in the treatment of unclippable cerebral aneurysms. J Neurosurg 1987; 66: 40-46.
59. Todd NV. Aneurysm rebleeding after treatments that leave the aneurysm sac patent. Br J Neurosurg 1990; 4(5): 373-379.
60. Minakawa T, Koike T, Fujii Y, et al. Long term results of ruptured aneurysms treated by coating. Neurosurgery 1987; 21(5): 660-663.
61. Qureshi AI, Frankel MR. Recognition and management of subarachnoid hemorrhage. Heart Disease & Stroke 1994; 3(5): 270-274.
62. Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 1988; 23(6): 699-704.
63. Solomon RA, Post KD, McMurtry JGD. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 1984; 15(3): 354-361.
64. Hart RG, Byer JA, Slaughter JR, Hewett JE, Easton JD. Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery 1981; 8(4): 417-421.
65. Ukkola V, Heikkinen ER. Epilepsy after operative treatment of ruptured cerebral aneurysms. Acta Neurochir 1990; 106(3-4): 115-118.
66. Ohman J. Hypertension as a risk factor for epilepsy after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 1990; 27(4): 578-581.
67. Hasan D, Schonck RS, Avezaat CJ, et al. Epileptic seizures after subarachnoid hemorrhage. Ann Neurol 1993; 33(3): 286-291.
68. Keranen T, Tapaninaho A, Hernesniemi J, et al. Late epilepsy after aneurysm operations. Neurosurgery 1985; 17: 897-900.
69. Sundaram MB, Chow F. Seizures associated with spontaneous subarachnoid hemorrhage. Can J Neurol Sci 1986; 13(3): 229-231.
70. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 1989; 298(6674): 636-642.
71. Ohman J, Servo A, Heiskanen O. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 1991; 74(1): 8-13.
72. Alien GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308(11): 619-624.
73. Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 1988; 22(3): 484-491.
74. Petruk KC, West M, Mohr G, et al. Nimodipine treatment in poorgrade aneurysm patients: results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988; 68: 505-517.
75. Philippon J, Grob R, Dagreou F, et al. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 1986; 82(3-4): 110-114.
76. Robinson MJ, Teasdale GM. Calcium antagonists in the management of subarachnoid haemorrhage. Cerebrovasc Brain Met Rev 1990; 2(3): 205-226.
77. Barker FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996; 84: 405-414.
78. Findlay JM, Macdonald RL, Weir BK. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Met Rev 1991; 3(4): 336-361.
79. Findlay JM, Kassell NF, Weir BKA, et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995; 37: 168-178.
80. Findlay JM, Weir BK, Kassell NF, Disney LB, Grace MG. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75(2): 181-188.
81. Hutchison K, Weir B. Transcranial Doppler studies in zneurysm patients. Can J Neurol Sci 1989; 16(4): 411-416.
82. Romner B, Ljunggren B, Brandt L, Saveland H. Correlation of transcranial Doppler sonography findings with timing of aneurysm surgery. J Neurosurg 1990; 73(1): 72-76.
83. Sekhar LN, Wechsler LR, Yonas H, Luyckx K, Obrist W. Value of transcranial Doppler examination in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1988; 22(5): 813-821.
84. Miller JD, Smith RR. Transcranial Doppler sonography in aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Met Rev 1994; 6(1): 31-46.
85. Trumble ER, Muizelaar JP, Myseros JS, Choi SC, Warren BB. Coagulopathy with the use of hetastarch in the treatment of vasospasm. J Neurosurg 1995; 82: 44-47.
86. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18(2): 365-372.
87. Kassell NF, Peerless SJ, Durward QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11(3): 337-343.
88. Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 1990; 27(5): 729-739; discussion 739-740.
89. Archer DP, Shaw DA, Leblanc RL, Tranmer BI. Haemodynamic considerations in the management of patients with subarachnoid haemorrhage. Can J Anaes 1991; 38: 454-470.
90. Hino A, Ueda S, Mizukawa N, Imahori Y, Hiroshi T. Effect of hemodilution on cerebral hemodynamics and oxygen metabolism. Stroke 1992; 23: 423-426.
91. Levy ML, Day JD, Zelman V, Giannotta SL. Cardiac performance enhancement and hypervolemic therapy. Neurosurg Clin N Am 1994; 5(4): 725-739.
92. Rosenwasser RH, Jallo JI, Getch CC, Liebman, KE. Complications of Swan-Ganz catheterization for hemodynamic monitoring in patients with subarachnoid hemorrhage. Neurosurgery 1995; 37: 872-876.
93. Miller JA, Dacey RG Jr, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995; 26: 2260-2266.
94. Barnwell SL, Higashida RT, Halbach VV, et al.Transluminal angioplasty of intracerebral vessels for cerebral arterial spasm: reversal of neurological deficits after delayed treatment. Neurosurgery 1989; 25(3): 424-429.
95. Coyne TJ, Montanera WJ, Macdonald RL, Wallace MC. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 1994; 37(5): 391-396.
96. Zubkov YN. Treatment of patients with intracranial arterial aneurysms in the haemorrhagic period. Neurol Res 1994; 16(1): 6-8.
97. Livingston K, Guterman LR, Hopkins LN. Intraarterial papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage [published erratum appears in Am J Neuroradiol 1993 Jul-Aug; 14(4): 1025]. Am J Neuroradiol 1993; 14(2): 346-347.
98. Saveland H, Hillman J, Brandt L, et al. Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 1992; 76(5): 729-734.
99. Saveland H, Brandt L. Which are the major determinants for outcome in aneurysmal subarachnoid hemorrhage? A prospective total management study from a strictly unselected series. Acta Neurol Scand 1994; 90(4): 245-250.
100. Proust F, Mannequin D, Langlois O, Freger, P, Creissard P. Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. The importance of control angiography Stroke 1995; 26: 1553-1557.
101. Le Roux PD, Elliott J, Downey L, et al. Improved outcome after rupture of anterior circulation aneurysms: a retrospective 10-year review of 224 good-grade patients. J Neurosurg 1995; 83: 394-402.
102. Hasan D, Tanghe HL. Distribution of cisternal blood in patients with acute hydrocephalus after subarachnoid hemorrhage. Ann Neurol 1992; 31(4): 374-378.
103. Graff-Radford NR, Torner J, Adams H Jr, Kassell NF. Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 1989; 46(7): 744-752.
104. Galera R, Greitz T. Hydrocephalus in the adult secondary to the rupture of intracranial arterial aneurysms. J Neurosurg 1970; 32(6): 634-641.
105. Raimondi AJ, Torres H. Acute hydrocephalus as a complication of subarachnoid hemorrhage. Surg Neurol 1973; 1(1): 23-26.
106. van Gijn J, Hijdra A, Wijdicks EF, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 1985; 63(3): 355-362.
107. Vassilouthis J, Richardson AE. Ventricular dilatation and communicating hydrocephalus following spontaneous subarachnoid hemorrhage. J Neurosurg 1979; 51(3): 341-351.
108. Mehta V, Holness RO, Connolly S, Walling S, Hall R. Acute hydrocephalus following aneurysmal subarachnoid hemorrhage. Can J Neurol Sci 1996; 23: 40-45.
109. Mayhall CG, Archer NH, Lamb VA, et al. Ventriculoscopy-related infections. A prospective epidemiologic study. N Engl J Med 1984; 310: 553-559.
110. Rhode V, Schaller C, Hassler HE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular hemorrhage. J Neurol Neurosurg Psychiatry 1995; 58: 447-451.
111. Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Bilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular hemorrhage. Acta Neurochir 1993; 122: 32-38.
112. Findlay JM, Grace MGA, Weir BKA. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 1993; 32: 941-947.
113. Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 1985; 17(2): 137-140.3
114. Diringer M, Ladenson PW, Stern BJ, Schleimer J, Hanley DF. Plasma atrial natriuretic factor and subarachnoid hemorrhage. Stroke 1988; 19(9): 1119-1124.
115. Harrigan MR. Cerebral salt wasting syndrome: a review. Neurosurgery 1996; 38: 152-160.